folder

Pharmacological targeting of AKAP-directed compartmentalized cAMP signalling

Authors

  • A. Dema
  • E. Perets
  • M.S. Schulz
  • V.A. Deák
  • E. Klussmann

Journal

  • Cellular Signalling

Citation

  • Cell Signal 27 (12): 2474-2487

Abstract

  • The second messenger cyclic adenosine monophosphate (cAMP) can bind and activate protein kinase A (PKA). The cAMP/PKA system is ubiquitous and involved in a wide array of biological processes and therefore requires tight spatial and temporal regulation. Important components of the safeguard system are the A-kinase anchoring proteins (AKAPs), a heterogeneous family of scaffolding proteins defined by its ability to directly bind PKA. AKAPs tether PKA to specific subcellular compartments, and they bind further interaction partners to create local signalling hubs. The recent discovery of new AKAPs and advances in the field that shed light on the relevance of these hubs for human disease highlight unique opportunities for pharmacological modulation. This review exemplifies how interference with signalling, particularly cAMP signalling, at such hubs can reshape signalling responses and discusses how this could lead to novel pharmacological concepts for the treatment of disease with an unmet medical need such as cardiovascular disease and cancer.


DOI

doi:10.1016/j.cellsig.2015.09.008